Family · Pharmaceutical analytical standards
Saxagliptin
A DPP-4 inhibitor (gliptin) for type 2 diabetes, approved in 2009: it slows the breakdown of incretins, the gut hormones that boost insulin release after meals. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Its structure contains an adamantane 'cage', a molecule whose name comes from the Greek adamantinos: its carbon atoms are arranged exactly as in a diamond crystal.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
